See more : RWE Aktiengesellschaft (RWE.SW) Income Statement Analysis – Financial Results
Complete financial analysis of USANA Health Sciences, Inc. (USNA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of USANA Health Sciences, Inc., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
You may be interested
- Latch, Inc. (LTCHW) Income Statement Analysis – Financial Results
- Interlink Telecom Public Company Limited (ITEL.BK) Income Statement Analysis – Financial Results
- NCC Limited (NCC.NS) Income Statement Analysis – Financial Results
- Mirum Pharmaceuticals, Inc. (MIRM) Income Statement Analysis – Financial Results
- América Móvil, S.A.B. de C.V. (AMOVF) Income Statement Analysis – Financial Results
USANA Health Sciences, Inc. (USNA)
About USANA Health Sciences, Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 921.01M | 998.60M | 1.19B | 1.13B | 1.06B | 1.19B | 1.05B | 1.01B | 918.50M | 790.47M | 718.18M | 648.73M | 581.94M | 517.64M | 436.94M | 429.01M | 423.15M | 374.19M | 327.74M | 272.82M | 200.01M | 133.78M | 114.28M | 123.18M | 129.40M | 121.60M | 85.20M | 56.70M | 24.50M | 7.30M |
| Cost of Revenue | 176.69M | 193.89M | 217.90M | 209.11M | 187.50M | 200.71M | 179.40M | 180.19M | 159.68M | 140.79M | 127.44M | 115.80M | 101.69M | 95.48M | 89.80M | 88.88M | 87.89M | 89.55M | 78.02M | 66.82M | 44.42M | 33.39M | 32.80M | 32.16M | 21.00M | 21.90M | 15.60M | 10.80M | 5.40M | 0.00 |
| Gross Profit | 744.32M | 804.71M | 968.57M | 925.53M | 873.40M | 988.54M | 867.86M | 825.89M | 758.82M | 649.68M | 590.74M | 532.92M | 480.25M | 422.16M | 347.14M | 340.13M | 335.26M | 284.65M | 249.73M | 206.00M | 155.59M | 100.38M | 81.48M | 91.02M | 108.40M | 99.70M | 69.60M | 45.90M | 19.10M | 7.30M |
| Gross Profit Ratio | 80.82% | 80.58% | 81.63% | 81.57% | 82.33% | 83.12% | 82.87% | 82.09% | 82.61% | 82.19% | 82.26% | 82.15% | 82.53% | 81.55% | 79.45% | 79.28% | 79.23% | 76.07% | 76.20% | 75.51% | 77.79% | 75.04% | 71.30% | 73.89% | 83.77% | 81.99% | 81.69% | 80.95% | 77.96% | 100.00% |
| Research & Development | 11.45M | 11.56M | 11.11M | 10.63M | 10.26M | 10.24M | 8.95M | 8.84M | 6.42M | 5.13M | 5.08M | 4.66M | 0.00 | 0.00 | 0.00 | 0.00 | 3.36M | 3.20M | 2.34M | 2.03M | 1.38M | 1.04M | 1.08M | 1.41M | 1.40M | 1.40M | 1.20M | 800.00K | 300.00K | 0.00 |
| General & Administrative | 256.99M | 262.30M | 279.11M | 261.19M | 267.73M | 275.06M | 265.09M | 234.19M | 209.00M | 184.53M | 166.21M | 154.24M | 402.99M | 353.95M | 296.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 434.79M | 519.27M | 487.86M | 459.48M | 525.13M | 470.26M | 453.08M | 408.16M | 349.04M | 307.82M | 280.51M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 256.99M | 697.10M | 798.37M | 749.04M | 727.21M | 800.19M | 735.36M | 687.27M | 617.16M | 533.58M | 474.03M | 434.74M | 402.99M | 353.95M | 296.35M | 292.14M | 261.19M | 219.11M | 189.02M | 159.13M | 123.09M | 86.56M | 76.20M | 79.97M | 88.50M | 79.70M | 55.60M | 36.40M | 15.00M | 0.00 |
| Other Expenses | 382.81M | 1.01M | 450.00K | 1.46M | 4.31M | 3.16M | 2.14M | -70.00K | 927.00K | -449.00K | -131.00K | 247.00K | 164.24M | 137.71M | 106.56M | 89.43M | 82.49M | 56.71M | 50.68M | 37.61M | 34.25M | 17.78M | 11.11M | 4.19M | 4.50M | 3.40M | 2.20M | 800.00K | 300.00K | 0.00 |
| Operating Expenses | 651.25M | 697.10M | 798.37M | 749.04M | 727.21M | 800.19M | 735.36M | 687.27M | 617.16M | 533.58M | 474.03M | 434.74M | 402.99M | 353.95M | 296.35M | 292.14M | 264.56M | 222.30M | 191.36M | 161.16M | 124.47M | 87.59M | 77.28M | 85.57M | 94.40M | 84.50M | 59.00M | 38.00M | 15.60M | 0.00 |
| Cost & Expenses | 827.94M | 890.99M | 1.02B | 958.15M | 914.71M | 1.00B | 914.76M | 867.46M | 776.84M | 674.37M | 601.46M | 550.55M | 504.68M | 449.43M | 386.15M | 381.02M | 352.45M | 311.85M | 269.38M | 227.98M | 168.89M | 120.98M | 110.08M | 117.73M | 115.40M | 106.40M | 74.60M | 48.80M | 21.00M | 0.00 |
| Interest Income | 9.64M | 3.79M | 2.52M | 2.54M | 4.71M | 4.43M | 2.19M | 1.48M | 1.12M | 500.00K | 464.00K | 247.00K | 191.00K | 167.00K | 82.00K | 249.00K | 0.00 | 0.00 | 0.00 | 572.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 262.00K | 192.00K | 57.00K | 507.00K | 66.00K | 36.00K | 46.00K | 444.00K | 15.00K | 129.00K | 1.00K | 20.00K | 9.00K | 94.00K | 609.00K | 792.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 20.40M | 21.41M | 22.19M | 22.51M | 22.79M | 16.73M | 15.96M | 13.48M | 9.98M | 8.81M | 9.04M | 8.83M | 8.47M | 7.92M | 7.07M | 6.70M | 5.33M | 5.56M | 5.90M | 4.84M | 3.88M | 4.14M | 4.12M | 4.19M | 4.50M | 3.40M | 2.20M | 800.00K | 300.00K | 0.00 |
| EBITDA | 123.11M | 130.22M | 192.89M | 200.96M | 146.19M | 188.35M | 132.50M | 152.10M | 151.64M | 124.91M | 125.76M | 107.27M | 85.96M | 76.87M | 58.66M | 53.81M | 76.03M | 69.43M | 64.77M | 49.92M | 31.12M | 12.79M | 4.20M | 5.46M | 18.50M | 18.60M | 12.80M | 8.70M | 3.80M | 7.30M |
| EBITDA Ratio | 13.37% | 10.78% | 14.34% | 15.55% | 13.78% | 15.84% | 12.65% | 13.78% | 15.42% | 14.69% | 16.25% | 15.13% | 13.24% | 13.05% | 11.58% | 13.01% | 17.80% | 17.92% | 19.63% | 18.34% | 17.44% | 12.65% | 7.30% | 7.52% | 17.70% | 15.13% | 14.79% | 14.81% | 14.69% | 100.00% |
| Operating Income | 93.07M | 107.61M | 170.19M | 176.49M | 146.19M | 188.35M | 132.50M | 138.62M | 141.66M | 116.10M | 116.71M | 98.18M | 77.26M | 68.22M | 50.79M | 48.00M | 70.70M | 62.34M | 58.36M | 44.85M | 31.12M | 12.79M | 4.20M | 5.46M | 14.00M | 15.20M | 10.60M | 7.90M | 3.50M | 7.30M |
| Operating Income Ratio | 10.11% | 10.78% | 14.34% | 15.55% | 13.78% | 15.84% | 12.65% | 13.78% | 15.42% | 14.69% | 16.25% | 15.13% | 13.28% | 13.18% | 11.62% | 11.19% | 16.71% | 16.66% | 17.81% | 16.44% | 15.56% | 9.56% | 3.68% | 4.43% | 10.82% | 12.50% | 12.44% | 13.93% | 14.29% | 100.00% |
| Total Other Income/Expenses | 9.38M | 1.01M | 450.00K | 1.46M | 4.31M | 3.16M | 2.14M | -70.00K | 927.00K | -449.00K | -131.00K | 247.00K | 222.00K | 648.00K | 187.00K | -1.68M | 471.00K | 1.41M | 487.00K | 233.00K | 192.00K | -221.00K | -692.00K | -677.00K | -4.45M | 200.00K | 100.00K | 200.00K | 200.00K | -7.30M |
| Income Before Tax | 102.45M | 108.62M | 170.64M | 177.95M | 150.50M | 191.51M | 134.64M | 138.55M | 142.59M | 115.65M | 116.58M | 98.43M | 77.48M | 68.86M | 50.98M | 46.32M | 71.17M | 63.75M | 58.85M | 45.08M | 31.31M | 12.57M | 3.51M | 4.78M | 9.60M | 15.40M | 10.70M | 8.10M | 3.70M | 0.00 |
| Income Before Tax Ratio | 11.12% | 10.88% | 14.38% | 15.68% | 14.19% | 16.10% | 12.86% | 13.77% | 15.52% | 14.63% | 16.23% | 15.17% | 13.31% | 13.30% | 11.67% | 10.80% | 16.82% | 17.04% | 17.96% | 16.52% | 15.65% | 9.40% | 3.07% | 3.88% | 7.42% | 12.66% | 12.56% | 14.29% | 15.10% | 0.00% |
| Income Tax Expense | 38.67M | 39.27M | 54.14M | 53.28M | 49.97M | 65.29M | 72.11M | 38.51M | 47.92M | 39.02M | 37.56M | 31.99M | 26.73M | 23.21M | 17.42M | 16.38M | 25.24M | 22.49M | 19.86M | 14.30M | 10.49M | 4.07M | 1.31M | 1.91M | 3.70M | 5.90M | 4.10M | 3.10M | 1.40M | -300.00K |
| Net Income | 63.79M | 69.35M | 116.51M | 124.66M | 100.53M | 126.22M | 62.54M | 100.04M | 94.67M | 76.64M | 79.02M | 66.43M | 50.75M | 45.65M | 33.56M | 29.95M | 45.32M | 41.27M | 38.99M | 30.78M | 20.82M | 8.50M | 2.20M | 2.87M | 5.90M | 9.50M | 6.60M | 5.00M | 2.30M | 300.00K |
| Net Income Ratio | 6.93% | 6.94% | 9.82% | 10.99% | 9.48% | 10.61% | 5.97% | 9.94% | 10.31% | 9.69% | 11.00% | 10.24% | 8.72% | 8.82% | 7.68% | 6.98% | 10.71% | 11.03% | 11.90% | 11.28% | 10.41% | 6.36% | 1.92% | 2.33% | 4.56% | 7.81% | 7.75% | 8.82% | 9.39% | 4.11% |
| EPS | 3.31 | 3.60 | 5.78 | 5.89 | 4.44 | 5.36 | 2.60 | 4.09 | 3.71 | 3.11 | 2.85 | 2.40 | 1.70 | 1.43 | 1.10 | 0.94 | 1.36 | 1.15 | 1.03 | 0.81 | 0.55 | 0.23 | 0.06 | 0.07 | 0.12 | 0.18 | 0.13 | 0.10 | 0.05 | 0.01 |
| EPS Diluted | 3.30 | 3.59 | 5.73 | 5.86 | 4.41 | 5.12 | 2.53 | 3.99 | 3.59 | 2.80 | 2.78 | 2.23 | 1.63 | 1.43 | 1.09 | 0.93 | 1.32 | 1.10 | 0.99 | 0.76 | 0.49 | 0.21 | 0.06 | 0.07 | 0.12 | 0.17 | 0.12 | 0.10 | 0.05 | 0.01 |
| Weighted Avg Shares Out | 19.25M | 19.25M | 20.15M | 21.16M | 22.64M | 23.57M | 24.02M | 24.49M | 24.98M | 25.27M | 27.77M | 27.64M | 29.88M | 30.62M | 30.70M | 32.10M | 33.47M | 36.11M | 37.75M | 38.33M | 38.04M | 37.77M | 38.71M | 39.15M | 48.63M | 51.75M | 50.96M | 50.00M | 43.81M | 40.00M |
| Weighted Avg Shares Out (Dil) | 19.35M | 19.31M | 20.34M | 21.26M | 22.82M | 24.64M | 24.71M | 25.05M | 26.35M | 27.38M | 28.41M | 29.85M | 31.15M | 31.88M | 30.86M | 32.33M | 34.41M | 37.45M | 39.44M | 40.83M | 42.64M | 41.29M | 38.82M | 39.56M | 49.89M | 55.72M | 53.28M | 52.63M | 46.00M | 40.00M |
USANA Health Sciences, Inc. (USNA) Q4 2023 Earnings Call Transcript
USANA Health Sciences, Inc. (USNA) Q4 2023 Earnings Call Transcript
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
USANA Health Sciences (USNA) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.66 per share a year ago.
USANA Health Sciences Reports Fourth Quarter and Fiscal Year 2023 Results
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and fiscal year ended December 30, 2023. Key Financial Results & Guidance Fourth quarter net sales were $221 million versus $228 million...
Kevin Guest Calls on All to Connect during February Month of Friendship
Cites 3 Benefits of In-Person Contact SALT LAKE CITY , Feb. 1, 2024 /PRNewswire/ -- February's International Friendship Month is a time for people everywhere to strengthen personal connections in an age where digital communication dominates. "There's nothing more important...
USANA Manufacturing Facility Receives Coveted GFSI Certification from SQF
Prestigious validation added for USANA product quality and safety SALT LAKE CITY , Jan. 25, 2024 /PRNewswire/ -- Quality is at the core of everything USANA does, and this drive for excellence is especially apparent in the way the company...
USANA to Continue Investing in Local Community after Decades-Long Amphitheatre Sponsorship Ends
SALT LAKE CITY , Jan. 23, 2024 /PRNewswire/ -- After a 20-year sponsorship, the USANA Amphitheatre will sport a new name. This change allows USANA Health Sciences, Inc., to focus on supporting other vital community-building projects.
USANA Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that fourth quarter and fiscal year 2023 results will be released after the close of market on Tuesday, February 6, 2024. Shortly following the issuance of the Company's earnings release,...
Kevin Guest Names 2024 the Year of Connection
Calls Out Digital Disconnection Paradox SALT LAKE CITY , Jan. 3, 2024 /PRNewswire/ -- In what some call the era of digital disconnection, 2024 should be the year of human connection to fight loneliness and anxiety, according to one health sciences...
USANA Health Sciences to Participate in the 2024 ICR Conference
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that it will host investor meetings and a fireside chat presentation at the ICR Conference...
USANA Kids Eat Spreads Holiday Cheer with Meals for Utah Students and Families
More than 4,300 bags of food distributed to local schools SALT LAKE CITY , Dec. 20, 2023 /PRNewswire/ -- The holiday season is a time of joy, but it can also be stressful for children who rely on in-school meals as...
Source: https://incomestatements.info
Category: Stock Reports